Sriram Krishnamurthy Peruvemba
Known title: DirectorCIK: 0001656093
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
SMTK Noted in After-Market Activity Lists. SmartKem stock was included in recent lists of information technology stocks showing activity during Friday's after-market session. This suggests increased trading interest or volatility outside regular hours. The stock has a wide 52-week range, indicating high historical price movement.
Transaction History
| DVLT | ▲ Buy | Grant | 250,000 | $0 | 4/20/2026 | View on chart |
| DVLT | ▲ Buy | Grant | 211,203 | $0 | 11/25/2025 | View on chart |
| DVLT | ▲ Buy | Grant | 26,372 | $0 | 6/25/2025 | View on chart |
| DVLT | ▲ Buy | Grant | 74,334 | $0 | 2/26/2025 | View on chart |
| DVLT | ▲ Buy | Grant | 7,422 | $0 | 11/12/2024 | View on chart |
| DVLT | ▲ Buy | Grant | 7,541 | $0 | 7/30/2024 | View on chart |
| DVLT | ▲ Buy | Grant | 4,616 | $0 | 6/7/2024 | View on chart |
| SMTK | ▲ Buy | Grant | 100 | $0 | 1/31/2024 | View on chart |
| DVLT | ▲ Buy | Grant | 11,000 | $0 | 7/12/2023 | View on chart |
| DVLT | ▲ Buy | Grant | 12,000 | $0 | 1/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
DataMeds AI files DBAs for new health entities
DataMeds AI, the parent company of Datavault AI, has filed DBAs for 'DataMeds SI' and 'Corexa Health SI.' These filings suggest the company is expanding its operations into specific health-related segments. The move provides context for the stock's current trading levels relative to its 52-week range.
DataMeds AI files DBAs for new health entities. DataMeds AI, the parent company of Datavault AI, has filed DBAs for 'DataMeds SI' and 'Corexa Health SI.' These filings suggest the company is expanding its operations into specific health-related segments. The move provides context for the stock's current trading levels relative to its 52-week range.